Advance in the development of modified vaccinia virus Ankara (MVA)vectors for novel influenza vaccines / 中国人兽共患病学报
Chinese Journal of Zoonoses
; (12): 222-227, 2017.
Article
em Zh
| WPRIM
| ID: wpr-511563
Biblioteca responsável:
WPRO
ABSTRACT
Influenza,caused by influenza virus,is a respiratory infectious disease with a serious hazard to human health.Prevention of influenza through vaccine development is the most effective strategy.It is important to build a rapid response platform for research and production of influenza vaccine.As virus vectors,live vaccine provides a new prevention and treatment way for infectious disease.Modified vaccinia virus Ankara(MVA) is a replication-deficient viral vector that is safe and can encode one or more foreign antigens and induce humoral and cellular immune response.MVA holds great promise as a vaccine platform.In this review,we discuss the use of MVA for vaccine development against influenza virus.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Zoonoses
Ano de publicação:
2017
Tipo de documento:
Article